AI-designed virus infects person for the first time

In a groundbreaking trial, an individual recently became the first person to receive a treatment containing an AI-designed virus. The company behind the treatment, Radical Numerics, announced this development in a report this week. The AI model utilized by Radical Numerics, named Omnii-1, generated a phage virus, a type of virus already used in experimental phage therapy treatments. Phage therapy involves administering viruses that target bacteria to combat serious bacterial infections, sparing human cells in the process.

Omnii-1's AI model was specifically tasked with designing a phage to target the patient's unique bacterial infection, marking the first time a phage created by an AI model has been administered to a human. However, the trial's progress and outcomes remain shrouded in mystery. Radical Numerics has not disclosed any information about the patient, the doctors involved, or the treatment's efficacy.

The company has not even shared the results of the trial with independent reviewers, as it has not undergone peer review or been published in a scientific journal.

CEO Eric Nguyen stated that the team intends to share more details once they obtain consent from the patient. This delay is attributed to confidentiality agreements. As phage therapy can take days to weeks to show results, and requires months of follow-up to ensure the infection has been fully eradicated, the waiting game continues.